News | March 14, 2023
Pfizer acquires Seagen for US$ 43 billion to battle cancer
Proposed combination enhances Pfizer’s position as a leading company in oncology
Proposed combination enhances Pfizer’s position as a leading company in oncology
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
The company will be submitting the responses to US FDA observations within stipulated timeline
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
The inspection concluded with no observations
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
Subscribe To Our Newsletter & Stay Updated
